Qingxin Xia

1.1k total citations
70 papers, 671 citations indexed

About

Qingxin Xia is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Qingxin Xia has authored 70 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Pathology and Forensic Medicine. Recurrent topics in Qingxin Xia's work include Lymphoma Diagnosis and Treatment (11 papers), Esophageal Cancer Research and Treatment (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Qingxin Xia is often cited by papers focused on Lymphoma Diagnosis and Treatment (11 papers), Esophageal Cancer Research and Treatment (9 papers) and Gastric Cancer Management and Outcomes (9 papers). Qingxin Xia collaborates with scholars based in China, United States and Japan. Qingxin Xia's co-authors include Takuya Maekawa, Yuqing Lan, Jing Chang, Yi Wang, He Zhang, Junfeng Chu, Qilong Gao, Xiaoqian Wang, Tao Huang and Atsushi Wada and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Qingxin Xia

63 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingxin Xia China 15 247 168 166 126 81 70 671
Chenyang Tao China 16 191 0.8× 129 0.8× 264 1.6× 182 1.4× 97 1.2× 42 762
Antonio Martínez‐Torteya Mexico 10 171 0.7× 163 1.0× 445 2.7× 202 1.6× 40 0.5× 32 827
Vidya Kamath United States 9 316 1.3× 166 1.0× 371 2.2× 194 1.5× 52 0.6× 23 843
Yajie Hu China 9 190 0.8× 148 0.9× 56 0.3× 62 0.5× 63 0.8× 26 468
Vilppu J. Tuominen Finland 12 285 1.2× 134 0.8× 295 1.8× 164 1.3× 54 0.7× 13 816
Dong–Hua Luo China 16 210 0.9× 241 1.4× 170 1.0× 128 1.0× 158 2.0× 47 737
Yanhong Wang China 18 283 1.1× 126 0.8× 194 1.2× 201 1.6× 184 2.3× 57 1.1k
Jianchao Wang China 19 163 0.7× 84 0.5× 214 1.3× 70 0.6× 43 0.5× 95 1.0k
Zhenqiu Liu United States 15 195 0.8× 217 1.3× 347 2.1× 147 1.2× 180 2.2× 31 929
Can Hu China 17 308 1.2× 279 1.7× 443 2.7× 197 1.6× 137 1.7× 95 1.1k

Countries citing papers authored by Qingxin Xia

Since Specialization
Citations

This map shows the geographic impact of Qingxin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxin Xia more than expected).

Fields of papers citing papers by Qingxin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingxin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxin Xia. The network helps show where Qingxin Xia may publish in the future.

Co-authorship network of co-authors of Qingxin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Qingxin Xia. A scholar is included among the top collaborators of Qingxin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingxin Xia. Qingxin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Chen, Wei, Mengyu Wang, Wenying Deng, et al.. (2024). Tumor-associated macrophage clusters linked to immunotherapy in a pan-cancer census. npj Precision Oncology. 8(1). 176–176. 8 indexed citations
5.
Wang, Yi, Yali Zhang, Yiping Jin, et al.. (2023). Intra-tumoral microbial community profiling and associated metabolites alterations of TNBC. Frontiers in Oncology. 13. 1143163–1143163. 9 indexed citations
6.
Chen, Yu, et al.. (2023). Case report: Clinicopathological and molecular characteristics of pediatric-type follicular lymphoma. Frontiers in Pediatrics. 11. 1205384–1205384. 4 indexed citations
7.
Chang, Jing, et al.. (2023). Potential values of formalin-fixed paraffin-embedded tissues for intratumoral microbiome analysis in breast cancer. Heliyon. 9(6). e16267–e16267. 7 indexed citations
8.
Lu, Haizhen, Dong Kuang, Ping Zhou, et al.. (2023). PD-L1 expression in recurrent or metastatic head and neck squamous cell carcinoma in China (EXCEED study): a multicentre retrospective study. Journal of Clinical Pathology. 78(2). 88–95. 2 indexed citations
9.
Wang, Chengzheng, Zhenzhen Liu, Xiuchun Chen, et al.. (2023). Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial. Nature Communications. 14(1). 6654–6654. 15 indexed citations
10.
Li, Sen, Ké Li, Hongle Li, et al.. (2023). A high interferon gamma signature of CD8+ T cells predicts response to neoadjuvant immunotherapy plus chemotherapy in gastric cancer. Frontiers in Immunology. 13. 1056144–1056144. 12 indexed citations
11.
Zhang, Xin, et al.. (2022). Genetic Alteration and Their Significance on Clinical Events in Small Cell Lung Cancer. SHILAP Revista de lepidopterología. 4 indexed citations
12.
Xia, Qingxin, et al.. (2022). MGA-Net+: Acceleration-based packaging work recognition using motif-guided attention networks. Pervasive and Mobile Computing. 88. 101735–101735.
14.
Qu, Jinrong, Yu‐Dong Zhang, Shuang Lü, et al.. (2022). Quantitative RECIST derived from multiparametric MRI in evaluating response of esophageal squamous cell carcinoma to neoadjuvant therapy. European Radiology. 32(10). 7295–7306. 11 indexed citations
15.
Hu, Yanping, Jiuzhou Zhao, Yihang Shen, et al.. (2022). Predictive value of tumor-infiltrating lymphocytes detected by flow cytometry in colorectal cancer. International Immunopharmacology. 113(Pt A). 109286–109286. 5 indexed citations
16.
Yan, Zheng, Wenping Zhou, Zhihua Yao, et al.. (2020). A genetic predictive model for precision treatment of diffuse large B-cell lymphoma with early progression. Biomarker Research. 8(1). 33–33. 11 indexed citations
17.
Zhang, Yusong, et al.. (2020). Inhibition of EZH2 attenuates inhibitory synaptic transmission via the pro-inflammatory pathway in rats. Neuropharmacology. 171. 108101–108101. 1 indexed citations
18.
Zhang, Tianshun, Ruihua Bai, Qiushi Wang, et al.. (2019). Fluvastatin Inhibits HMG-CoA Reductase and Prevents Non–Small Cell Lung Carcinogenesis. Cancer Prevention Research. 12(12). 837–848. 24 indexed citations
19.
Li, Xu, Wei Li, Dong‐Mei Zhao, et al.. (2019). The correlation of the levels of interleukin-15 with late onset myasthenia gravis. Chin J Neurol. 52(6). 446–451. 1 indexed citations
20.
Ying, Jianming, L. Li, Qingxin Xia, et al.. (2019). P1.09-05 ALK Testing in Chinese Advanced NSCLC Patients: A National-Wide Multicenter Prospective Real-World Data Study (The RATICAL Study). Journal of Thoracic Oncology. 14(10). S497–S497. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026